Comprehensive, condensed new edition covering the entire specialties of Hematology/Oncology and Cellular Therapy (Volumes 1 and 2) Cancer Consult: Expertise for Medical Oncology/Hematology and Cellular Therapy, Second Edition includes hundreds of painstakingly developed multiple-choice and open-ended questions covering the principles, uncertainties, and controversies of medical oncology, neoplastic hematology, hematopoietic stem cell transplant and cellular therapies including comprehensive chapters on different aspect of cancer supportive care. This textbook also contains mini-cases and questions dealing with the biology, diagnosis, classification, staging, and multidisciplinary treatment of cancers. This book also includes: Streamlined, engaging content to make finding information easier and more beneficial to the reader Up-to-date information on the very latest topics such as molecular techniques, targeted therapies, immunotherapy, cellular therapy, CAR T-cell therapy and translational cancer research Concise and practical expert perspectives that reference key studies and journals References to the latest NCCN and other national guidelines With its powerful focus on pragmatic clinical diagnostic, therapeutic and prognostic approaches, Cancer Consult: Expertise for Medical Oncology/Hematology and Cellular Therapy, Second Edition (Volumes 1 and 2) will help keep hematology, oncology and cellular therapy practitioners up-to-date, bridging the gaps between journal and reference literature, conferences, and their existing knowledge base. It also offers clinicians, trainees, and fellows an excellent opportunity to enhance their preparation for the ABIM hematology and oncology fellowship and recertification exams onboards.

Comprehensive, condensed new edition covering the entire specialties of Hematology/Oncology and Cellular Therapy (Volumes 1 and 2) Cancer Consult: Expertise for Medical Oncology/Hematology and Cellular Therapy, Second Edition includes hundreds of painstakingly developed multiple-choice and open-ended questions covering the principles, uncertainties, and controversies of medical oncology, neoplastic hematology, hematopoietic stem cell transplant and cellular therapies including comprehensive chapters on different aspect of cancer supportive care. This textbook also contains mini-cases and questions dealing with the biology, diagnosis, classification, staging, and multidisciplinary treatment of cancers. This book also includes: Streamlined, engaging content to make finding information easier and more beneficial to the reader Up-to-date information on the very latest topics such as molecular techniques, targeted therapies, immunotherapy, cellular therapy, CAR T-cell therapy and translational cancer research Concise and practical expert perspectives that reference key studies and journals References to the latest NCCN and other national guidelines With its powerful focus on pragmatic clinical diagnostic, therapeutic and prognostic approaches, Cancer Consult: Expertise for Medical Oncology/Hematology and Cellular Therapy, Second Edition (Volumes 1 and 2) will help keep hematology, oncology and cellular therapy practitioners up-to-date, bridging the gaps between journal and reference literature, conferences, and their existing knowledge base. It also offers clinicians, trainees, and fellows an excellent opportunity to enhance their preparation for the ABIM hematology and oncology fellowship and recertification exams onboards.

This book comprehensively summarizes the current state of knowledge on malignancies of the gastrointestinal tract. Dedicated organ-based chapters evaluate current treatments and management and provide information on incidence, etiology and biological characteristics. The state of the art in the radiologic and endoscopic staging of gastrointestinal malignancies is described, and guidance is offered on the role of interventional radiology and interventional gastroenterology in the treatment of these challenging tumors. In addition, the book explores novel and evolving treatments, including personalized systemic therapy and minimally invasive surgical and radiology techniques, and addresses patient-reported outcomes and survivorship challenges. It closes by discussing animal models of gastrointestinal malignancies and examining the significance of the Ras superfamily of GTPases. It will be of benefit to all surgeons, oncologists and other specialists who treat these malignancies, as well as to trainees looking to increase their understanding of the field.